300149 Stock Overview
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
ChemPartner PharmaTech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.74 |
52 Week High | CN¥9.03 |
52 Week Low | CN¥3.68 |
Beta | 0.82 |
11 Month Change | -3.58% |
3 Month Change | 49.11% |
1 Year Change | -22.17% |
33 Year Change | -54.86% |
5 Year Change | -48.59% |
Change since IPO | -53.65% |
Recent News & Updates
Recent updates
Shareholder Returns
300149 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 5.3% | 0.1% | -0.6% |
1Y | -22.2% | -19.8% | 3.2% |
Return vs Industry: 300149 underperformed the CN Biotechs industry which returned -20.9% over the past year.
Return vs Market: 300149 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
300149 volatility | |
---|---|
300149 Average Weekly Movement | 13.3% |
Biotechs Industry Average Movement | 9.0% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300149's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300149's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 1,916 | Swee Lian Woo | www.cppt.com.cn |
Chempartner Pharmatech Co., Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services.
ChemPartner PharmaTech Co.,Ltd. Fundamentals Summary
300149 fundamental statistics | |
---|---|
Market cap | CN¥3.36b |
Earnings (TTM) | -CN¥938.29m |
Revenue (TTM) | CN¥1.01b |
3.3x
P/S Ratio-3.6x
P/E RatioIs 300149 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300149 income statement (TTM) | |
---|---|
Revenue | CN¥1.01b |
Cost of Revenue | CN¥817.12m |
Gross Profit | CN¥193.60m |
Other Expenses | CN¥1.13b |
Earnings | -CN¥938.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.88 |
Gross Margin | 19.15% |
Net Profit Margin | -92.83% |
Debt/Equity Ratio | 9.8% |
How did 300149 perform over the long term?
See historical performance and comparison